Hadassah

Abandoned Baby Receives Life-Saving Heart Surgery at Hadassah

Monday, Dec 9 2013

When "Rami," just a few days old, was found in a box on a street in Bethlehem, someone brought him to the Bethlehem Creche, a nearby orphanage. Born with a serious heart problem, he was referred to Hadassah Hospital-Ein Kerem for life-saving surgery and now is recovering in the Pediatric Intensive Care Unit (PICU).

The nuns at the Creche first brought the baby to Bethlehem's Caritas Baby Hospital, where physicians diagnosed a coarctation of the aorta (a narrowing of the major blood vessel that carries blood from the heart to the body). Without corrective surgery, they knew he would die.

"I received a call from the cardiologist and we said we'd find space for him as soon as possible," relates Hadassah Pediatric Cardiothoracic Surgeon Dr. Eldad Erez. "In a newborn, the heart is the size of his fist," he explains. "We plan out the surgery ahead of time and try to be as precise as possible."

Dr. Erez reports that, following this successful surgery, Rami's prognosis is excellent. He adds: "I'm a father of four and, as a dad, I feel particularly happy that a child who has started his life with the double obstacles of abandonment and a congenital heart defect will have a chance at a normal life."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Monday, May 7 2018

Hadassah Cardiac Specialists Are Collaborating with Colleagues to Save Syrian Children

In an effort to save the lives of Syrian children suffering from life-threatening and complex heart abnormalities, the Hadassah Medical Organization and the Baruch Padeh Medical Center in Poriya-Tiberias have launched a unique collaboration as part of the Israel Defense Forces’ Good Neighbor program.

READ MORE ›
alt_text

Monday, May 7 2018

Pluristem Stem Cell Therapy, Based on Hadassah Preclinical Research, Has Been Cleared by FDA

Pluristem Therapeutics has announced that its new cell therapy to treat acute radiation syndrome (PLX-R18), based on the pioneering studies performed within the laboratory of Prof. Raphael Gorodetsky at the Hadassah Medical Organization, has received clearance from the United States Food and Drug Administration to treat individuals who may have been acutely exposed to high-dose radiation as the result of a nuclear attack or accident.

READ MORE ›
alt_text

Thursday, May 3 2018

HMO Exclusive Call with Nurse Rely Alon

Please join us for an exclusive conference call with Dr. Rely Alon, Director, Division of Nursing & Health Professions, Wednesday May 9, 2018 from 10:00 - 11:00 am EDT

READ MORE ›
alt_text

Tuesday, Apr 17 2018

Predicting Clinical Outcomes for Multiple Sclerosis Patients: Cutting-Edge Research at Hadassah

More than two million people--two to three times more women--have multiple sclerosis (MS)--the leading cause of neurological disability among young adults. What is their prognosis?

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More